Document Detail


2-BFI Ameliorates EAE-induced Mouse Spinal Cord Damage: Effective Therapeutic Time Window and Possible Mechanisms.
MedLine Citation:
PMID:  22985669     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Our previous studies showed that ligands to type 2 imidazoline receptors (I(2)R), including 2-(2-Benzofuranyl)-2-imidazoline (2-BFI) and Idazoxan, were effective in reducing spinal cord inflammation caused by experimental autoimmune encephalomyelitis (EAE). In the present study, we determined the effective therapeutic time window of 2-BFI and found that administration of 2-BFI in mice before the appearance of ascending flaccid paralysis (1-10 days post immunization), but not during the period when neurological deficits occurred (11-20 days post immunization), significantly ameliorated EAE-induced neurobehavioral deficits, reduced the infiltration of inflammatory cells into the spinal cord, and reduced the level of demyelination. More interestingly, giving 2-BFI during 1-10 days post immunization selectively suppressed IL-17 levels in the peripheral blood, which strongly suggests that IL-17 may be a good early marker to indicate EAE progression and that 2-BFI may target CD4(+) T lymphocytes, especially Th17 cells to reduce IL-17 expression. Collectively, these studies led us to envisage that 2-BFI can be a useful drug to treat multiple sclerosis (MS) when used in combination with an early indicator of MS progression, such as IL-17.
Authors:
Fang Li; Zheng-Xue Zhang; Yin-Feng Liu; Hui-Qin Xu; Sheng-Tao Hou; Rong-Yuan Zheng
Related Documents :
25419419 - Microrna-96 regulates rgc-5 cell growth through caspase-dependent apoptosis.
12226749 - Reaper and bax initiate two different apoptotic pathways affecting mitochondria and ant...
25292199 - Co-ordinated brain and craniofacial development depends upon patched1/xiap regulation o...
19579059 - Bax inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal carcinoma cells.
17139689 - Novel bcl-2 inhibitors: discovery and mechanism study of small organic apoptosis-induci...
25291319 - Stimulate the phagocytes.
21626289 - Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheropro...
11160319 - A redundant role of the cd3 gamma-immunoreceptor tyrosine-based activation motif in mat...
19024099 - Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-14
Journal Detail:
Title:  Brain research     Volume:  -     ISSN:  1872-6240     ISO Abbreviation:  Brain Res.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
Affiliation:
Department of Neurology, The First Affiliated Hospital and Research Institute of Experimental Neurobiology, Wenzhou Medical College, No. 2 Fuxue Lane, Wenzhou City, Zhejiang Province 325000, P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Specific quality of life factors in patients with inflammatory bowel disease].
Next Document:  A neurocognitive perspective on rhyme awareness: the N450 rhyme effect.